<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>N-terminal pro-brain natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> (NT-proBNP), which is a useful biomarker of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001635'>heart failure</z:hpo>, has been shown to be a strong predictor of cardiovascular mortality </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to evaluate the relationships between NT-proBNP and markers of subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Relationships of NT-proBNP to pulse wave velocity (PWV) or ankle-brachial index (ABI) as well as to various parameters, including body mass index, blood pressure, serum <z:chebi fb="23" ids="18059">lipid</z:chebi> concentration, serum <z:chebi fb="3" ids="27226">uric acid</z:chebi> concentration, and glycemic control (<z:chebi fb="0" ids="35143">hemoglobin</z:chebi> A1c), age, <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>, serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> concentration, severity of diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> or <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, current treatment of <z:mp ids='MP_0002055'>diabetes</z:mp>, cardiothoracic ratio on chest radiograph, presence of <z:hpo ids='HP_0001712'>left ventricular hypertrophy</z:hpo> and/or ST-T changes evaluated by electrocardiograph, smoking status and presence of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> were investigated in 323 consecutive patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Log (NT-proBNP) correlated positively with PWV (r = 0.283, p &lt; 0.0001) and correlated negatively with ABI (r = -0.144, p = 0.0094) </plain></SENT>
<SENT sid="4" pm="."><plain>Multiple regression analysis demonstrated that age (β = 0.200, p = 0.0033), systolic blood pressure (β = 0.246, p &lt; 0.0001), total cholesterol (β = -0.135, p = 0.0326), <z:chebi fb="3" ids="27226">uric acid</z:chebi> (β = 0.133, p = 0.0462), <z:chebi fb="0" ids="16737">creatinine</z:chebi> (β = -0.184, p = 0.0122), smoking status (β = -0.129, p = 0.0499) and log (NT-proBNP) (β = 0.177, p = 0.0149) were independently correlated with PWV and that systolic blood pressure (β = -0.145, p = 0.0310), log <z:chebi fb="0" ids="17855">triglyceride</z:chebi> (β = -0.151, p = 0.0397) and log (NT-proBNP) (β = -0.207, p = 0.0094) were independently correlated with ABI </plain></SENT>
<SENT sid="5" pm="."><plain>In conclusion, NT-proBNP could be a marker of subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>